CALML4 inhibitors are a specialized group of chemical compounds designed to target and inhibit the function of the protein Calmodulin-like 4 (CALML4). This protein is part of the calmodulin family, which plays a crucial role in calcium signaling by interacting with various proteins and enzymes, influencing cellular processes such as muscle contraction, cell division, and signal transduction. CALML4 inhibitors operate by binding to the CALML4 protein, thereby blocking its interaction with calcium ions and its target proteins. This interruption of CALML4's normal function affects calcium signaling pathways that rely on CALML4 for proper regulation and signal propagation. The specific inhibition of CALML4 by these compounds is critical, as it ensures that the downstream proteins and enzymes that depend on CALML4 for activation or repression are also indirectly modulated. The precision of CALML4 inhibitors lies in their ability to selectively interact with CALML4 without affecting other calmodulin family proteins, ensuring a high degree of specificity in their action.
The chemical composition and structure of CALML4 inhibitors are diverse, allowing for a range of interactions with the protein. These inhibitors may be designed to mimic the natural binding partners of CALML4, competitively binding to the active sites, or they might induce conformational changes in the protein that prevent its normal function. Because CALML4 is involved in numerous cellular pathways, the inhibition of this protein can have widespread effects on cellular signaling networks. The compounds typically exhibit high affinity for CALML4 and possess chemical properties that allow them to penetrate cellular membranes to reach intracellular targets. By fine-tuning the activity of CALML4, these inhibitors can indirectly influence various cellular outcomes associated with calcium signaling. The development and use of CALML4 inhibitors are driven by the need to understand the fundamental biological roles of CALML4 and to elucidate the complex pathways of calcium-dependent signaling within the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $163.00 $300.00 $1642.00 | 18 | |
W-7 is a calmodulin inhibitor that non-specifically binds to CALML4, disrupting its calcium-binding ability and therefore its regulatory function on downstream calcium-modulated pathways. | ||||||
Ophiobolin A | 4611-05-6 | sc-202266 sc-202266A sc-202266B | 100 µg 1 mg 5 mg | $43.00 $245.00 $714.00 | 7 | |
Ophiobolin A is an inhibitor of calmodulin-dependent processes, interacting with CALML4 to inhibit its function in cellular signaling pathways that depend on calcium signaling. | ||||||
Phenothiazine | 92-84-2 | sc-250686 sc-250686A | 50 g 250 g | $23.00 $43.00 | ||
Phenothiazine acts as a calmodulin inhibitor by binding to CALML4, which is essential for its role in calcium signaling, thus indirectly decreasing CALML4's activity. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $60.00 $108.00 | 21 | |
Chlorpromazine interacts with calmodulin, and by extension CALML4, inhibiting its regulatory role in calcium-mediated signaling pathways. | ||||||
Thioridazine | 50-52-2 | sc-473180 | 50 mg | $500.00 | ||
Thioridazine binds to calmodulin, of which CALML4 is a member, and inhibits its activity, thereby affecting the signaling pathways controlled by CALML4. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $367.00 | ||
Verapamil is a calcium channel blocker that indirectly affects CALML4 activity by altering intracellular calcium levels and thus calmodulin-dependent signaling pathways. | ||||||
Pimozide | 2062-78-4 | sc-203662 | 100 mg | $102.00 | 3 | |
Pimozide acts as a calmodulin antagonist and thereby can inhibit CALML4 function by preventing its interaction with calcium ions and target proteins. | ||||||
Calmidazolium chloride | 57265-65-3 | sc-201494 sc-201494A | 10 mg 50 mg | $153.00 $600.00 | 27 | |
Calmidazolium is a calmodulin inhibitor that binds to CALML4, inhibiting its activity and its role in modulating calcium-dependent signaling processes. | ||||||
Compound 48/80 trihydrochloride | 94724-12-6 | sc-200736 sc-200736A sc-200736B sc-200736C | 100 mg 250 mg 1 g 5 g | $102.00 $214.00 $826.00 $3682.00 | ||
Compound 48/80 interacts with calmodulin, thereby potentially inhibiting CALML4-mediated signaling by disrupting calmodulin's regulatory function. | ||||||